Menu

About
- Close
- Team
Services
Therapies
- Close
- Cell Therapy
- Gene Therapy
Events
News
Careers
Contact Us
Search

Home In the News New Jersey Innovation Institute Announces Sale of its Subsidiary, BioCentriq, for $73 Million

New Jersey Innovation Institute Announces Sale of its Subsidiary, BioCentriq, for $73 Million

June 9, 2022 Abigail Letson

Get Updates

Email*
CAPTCHA
Comments
This field is for validation purposes and should be left unchanged.

Δ

Topics

Biopharma

Recent Posts

BioCentriq Acquired by GC for $73 Million May 17, 2022
Haro Hartounian, Ph.D. Honored by ROI-NJ in 2021 List of ROI Influencers for Health Care October 25, 2021
Terumo Blood and Cell Technologies is collaborating with BioCentriq to provide technologies and expertise to automate cell and gene therapy manufacturing October 12, 2021

- Gene Therapy
- Cell Therapy
- Contact

© BIOCENTRIQ 2021. ALL RIGHTS RESERVED. | PRIVACY POLICY | TERMS OF USE

Type and Press “enter” to Search